EN
抗体药类似物
Research Grade Clazakizumab
All
TD-HY328056_1.jpg
TD-HY328056_2.jpg
TD-HY328056_3.jpg
  • CatalogTD-HY328056
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsALD-518, BMS-945429, CAS: 1236278-28-6
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Clazakizumab


Catalog No. TD-HY328056
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P05231
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names ALD-518, BMS-945429, CAS: 1236278-28-6
Background Clazakizumab is a monoclonal antibody with high affinity and specificity for the IL-6 (interleukin-6) cytokine. Clazakizumab may be helpful in inhibiting the cytokine response to SARS-CoV-2 in COVID-19. Clazakizumab can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection.
Note For research use only. Not suitable for clinical or therapeutic use.

 

TD-HY328056_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Clazakizumab.
TD-HY328056_2.jpg
Bioactivity
 
Detects Human IL6 in indirect ELISAs.
TD-HY328056_3.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Clazakizumab.